Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016

Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016

Chun-Hsing Liao,1,2 Na-Yao Lee,3 Hung-Jen Tang,4,5 Susan Shin-Jung Lee,6,7 Chin-Fu Lin,8 Po-Liang Lu,9–11 Jiunn-Jong Wu,12 Wen-Chien Ko,13 Wen-Sen Lee,14 Po-Ren Hsueh15,16 1Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan; 2Department of Medicine, Yang-Ming Un...

Full description

Bibliographic Details
Main Authors: Liao CH, Lee NY, Tang HJ, Lee SSJ, Lin CF, Lu PL, Wu JJ, Ko WC, Lee WS, Hsueh PR
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:Infection and Drug Resistance
Subjects:
carbapenem resistance
ceftazidime-avibactam
ceftolozane-tazobactam
carbapenemase genes
mcr
Online Access:https://www.dovepress.com/antimicrobial-activities-of-ceftazidime-avibactam-ceftolozane-tazobact-peer-reviewed-article-IDR

Internet

https://www.dovepress.com/antimicrobial-activities-of-ceftazidime-avibactam-ceftolozane-tazobact-peer-reviewed-article-IDR

Similar Items